Baystreet Staff - Monday, November 9, 2026 Oncolytics Biotech Inc 12:07 PM EST - Oncolytics Biotech Inc : Announced translational data in heavily pretreated relapsed/refractory multiple myeloma patients, which will be presented at the 68th American Society of Hematology Annual Meeting and Exposition. Oncolytics Biotech Inc shares N.ONCY are trading unchanged at $0.43. Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=ONCY&qmodStoryID=7952839035812098
